Is this you? Create Your Porfile
Avatar

Matteo D'anello

Pfizer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Matteo D'anello is active.

Explore More

Publication

Featured researches published by Matteo D'anello.

Archive | 2010

Heterobicyclic pyrazole derivatives as kinase inhibitors

Roberto Tonani; Simona Bindi; Daniele Fancelli; Valeria Pittalà; Matteo D'anello

Archive | 2004

Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them

Barbara Salom; Matteo D'anello; Maria Gabriella Brasca; Patrizia Giordano; Katia Martina; Francesco Angelucci; Frederick Arthur Brookfield; William John Trigg; Edward Andrew Boyd; Jonathan Anthony Larard

Archive | 2009

3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them

Giovanni Cervi; Matteo D'anello; Gianluca Papeo; Barbara Salom

Archive | 2002

Aminoindazole derivatives active as kinase inhibitors

Raffaella Amici; Matteo D'anello; Katia Martina; Barbara Salom; Anna Vulpetti

Archive | 2010

Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them

Barbara Salom; Matteo D'anello; Maria Gabriella Brasca; Patrizia Giordano; Katia Martina; Francesco Angelucci; Frederick Arthur Brookfield; William John Trigg; Edward Andrew Boyd; Jonathan Anthony Larard

Archive | 2011

Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors

Barbara Salom; Matteo D'anello; Maria Gabriella Brasca; Patrizia Giordano; Katia Martina; Dania Tesei; Frederick Arthur Brookfield; William John Trigg; Edward Andrew Boyd; Jonathan Anthony Larard

Archive | 2017

derivados de 3-fenil-isoquinolin-1(2h)-ona como inibidores de parp-1

Alessandra Cirla; Alessandra Scolaro; Fabio Zuccotto; Gianluca Papeo; Matteo D'anello

Archive | 2015

Substituted 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-ones as modulators of protein kinase activity

Danilo Mirizzi; Giovanni Cervi; Matteo D'anello; Gianluca Papeo; Ron Ferguson; Francesco Casuscelli

Archive | 2013

3,4-dihydro-2h-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases

Danilo Mirizzi; Giovanni Cervi; Matteo D'anello; Gianluca Papeo; Ron Ferguson; Francesco Casuscelli

Archive | 2009

Derivatives of 3,4-dihydro-2H-pyrazino [1,2-a] indol-1-one as active kinase inhibitors, process for their preparation and pharmaceutical compositions comprising

Giovanni Cervi; Matteo D'anello; Gianluca Papeo; Barbara Salom

Explore More

Collaboration

Dive into the Matteo D'anello's collaboration.

Top Co-Authors
Avatar

Barbara Salom

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Edward Andrew Boyd

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Frederick Arthur Brookfield

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Jonathan Anthony Larard

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Patrizia Giordano

Pfizer

View shared research outputs
Top Co-Authors
Avatar

William John Trigg

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Gianluca Papeo

University of Milan

View shared research outputs
Top Co-Authors
Avatar

Katia Martina

University of Turin

View shared research outputs
Top Co-Authors
Avatar

Maria Gabriella Brasca

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Giovanni Cervi

University of Milan

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge